These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29630769)

  • 1. Does N-terminal huntingtin function as a 'holdase' for inhibiting cellular protein aggregation?
    Sethi R; Tripathi N; Pallapati AR; Gaikar A; Bharatam PV; Roy I
    FEBS J; 2018 May; 285(10):1791-1811. PubMed ID: 29630769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core.
    Lin HK; Boatz JC; Krabbendam IE; Kodali R; Hou Z; Wetzel R; Dolga AM; Poirier MA; van der Wel PCA
    Nat Commun; 2017 May; 8():15462. PubMed ID: 28537272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation.
    Crick SL; Ruff KM; Garai K; Frieden C; Pappu RV
    Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20075-80. PubMed ID: 24282292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel caspase cleavage site in huntingtin that regulates mutant huntingtin clearance.
    Martin DDO; Schmidt ME; Nguyen YT; Lazic N; Hayden MR
    FASEB J; 2019 Mar; 33(3):3190-3197. PubMed ID: 30423259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation.
    Peskett TR; Rau F; O'Driscoll J; Patani R; Lowe AR; Saibil HR
    Mol Cell; 2018 May; 70(4):588-601.e6. PubMed ID: 29754822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
    Luo H; Cao L; Liang X; Du A; Peng T; Li H
    Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of elongated polyglutamine tracts by a helical peptide derived from N-terminal huntingtin.
    Sethi R; Roy I
    IUBMB Life; 2020 Jul; 72(7):1528-1536. PubMed ID: 32320524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of huntingtin aggregation by its N-terminal 17-residue peptide and its analogs.
    Belwal VK; Vijayakumar A; Chaudhary N
    Arch Biochem Biophys; 2021 Nov; 712():109033. PubMed ID: 34534539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
    Chen M; Wolynes PG
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
    Banerjee M; Datta M; Bhattacharyya NP
    Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of polyglutamine aggregation by SIMILAR huntingtin N-terminal sequences: Prospective molecules for preclinical evaluation in Huntington's disease.
    Burra G; Thakur AK
    Biopolymers; 2017 Jul; 108(4):. PubMed ID: 28406522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Terminal Fragments of Huntingtin Longer than Residue 170 form Visible Aggregates Independently to Polyglutamine Expansion.
    Chen MZ; Mok SA; Ormsby AR; Muchowski PJ; Hatters DM
    J Huntingtons Dis; 2017; 6(1):79-91. PubMed ID: 28339398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms.
    Pandey NK; Isas JM; Rawat A; Lee RV; Langen J; Pandey P; Langen R
    J Biol Chem; 2018 Feb; 293(7):2597-2605. PubMed ID: 29282287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The folding equilibrium of huntingtin exon 1 monomer depends on its polyglutamine tract.
    Bravo-Arredondo JM; Kegulian NC; Schmidt T; Pandey NK; Situ AJ; Ulmer TS; Langen R
    J Biol Chem; 2018 Dec; 293(51):19613-19623. PubMed ID: 30315108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphomimetic Mutations Impact Huntingtin Aggregation in the Presence of a Variety of Lipid Systems.
    Groover SE; Beasley M; Ramamurthy V; Legleiter J
    Biochemistry; 2020 Dec; 59(49):4681-4693. PubMed ID: 33256402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation.
    Wang J; Gines S; MacDonald ME; Gusella JF
    BMC Neurosci; 2005 Jan; 6():1. PubMed ID: 15649316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into the aggregation mechanism of huntingtin exon 1 protein fragment with different polyQ-lengths.
    Priya SB; Gromiha MM
    J Cell Biochem; 2019 Jun; 120(6):10519-10529. PubMed ID: 30672003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyglutamine expansion affects huntingtin conformation in multiple Huntington's disease models.
    Daldin M; Fodale V; Cariulo C; Azzollini L; Verani M; Martufi P; Spiezia MC; Deguire SM; Cherubini M; Macdonald D; Weiss A; Bresciani A; Vonsattel JG; Petricca L; Marsh JL; Gines S; Santimone I; Marano M; Lashuel HA; Squitieri F; Caricasole A
    Sci Rep; 2017 Jul; 7(1):5070. PubMed ID: 28698602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers.
    Posey AE; Ruff KM; Harmon TS; Crick SL; Li A; Diamond MI; Pappu RV
    J Biol Chem; 2018 Mar; 293(10):3734-3746. PubMed ID: 29358329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis.
    Cong SY; Pepers BA; Roos RA; van Ommen GJ; Dorsman JC
    Exp Neurol; 2006 Jun; 199(2):257-64. PubMed ID: 16380118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.